The field of pharmaceuticals is experiencing a significant shift towards the utilization of plant-based compounds for the treatment of neurological conditions. This emerging trend stems from growing research showcasing the therapeutic potential of cannabinoids and other plant-derived substances in managing disorders like Parkinson’s disease and others.
Investors are taking notice of this burgeoning market, driven by the promising prospects of these plant-inspired medications. This article delves into the key factors driving investment in this sector, the challenges faced, and the outlook for the future.